Detalles de la búsqueda
1.
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
Eur Heart J
; 43(10): 959-967, 2022 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34918066
2.
Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions - proceedings from the CEC Summit 2018.
Am Heart J
; 246: 93-104, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973948
3.
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
Eur Heart J
; 41(37): 3533-3545, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085967
4.
A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?
Circulation
; 134(23): 1881-1906, 2016 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27920074
5.
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.
Am Heart J
; 188: 147-155, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28577670
6.
A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease.
Am Heart J
; 181: 92-100, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27823698
7.
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.
Am Heart J
; 174: 120-8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26995378
8.
The Single-Syringe Versus the Double-Syringe Techniques of Adenosine Administration for Supraventricular Tachycardia: A Systematic Review and Meta-Analysis.
Am J Cardiovasc Drugs
; 23(4): 341-353, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37162718
9.
Corrigendum to "A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease" [Am Heart J 181 (2016) 92-100].
Am Heart J
; 184: 156, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28224931
10.
Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective.
Am J Cardiovasc Drugs
; 22(1): 93-104, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34331235
11.
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.
EuroIntervention
; 18(11): e897-e909, 2022 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35979636
12.
Prognosis of Claims- Versus Trial-Based Ischemic and Bleeding Events Beyond 1 Year After Coronary Stenting.
J Am Heart Assoc
; 10(6): e018744, 2021 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33682431
13.
Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials.
Eur Heart J Cardiovasc Pharmacother
; 7(FI1): f50-f60, 2021 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33119069
14.
Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals.
Clin Appl Thromb Hemost
; 25: 1076029619880008, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31588785
15.
The multiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events?
Eur Heart J Cardiovasc Pharmacother
; 7(3): e29-e30, 2021 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33340322
16.
Does Serum Bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI.
Angiology
; 65(3): 198-204, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23378197
17.
Relation of red cell distribution width with the presence, severity, and complexity of coronary artery disease.
Coron Artery Dis
; 23(1): 51-6, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22133925
18.
Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Am J Cardiol
; 110(5): 621-7, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22608360
19.
Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction.
Coron Artery Dis
; 22(3): 131-7, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21394027
20.
Advances in understanding percutaneous coronary intervention pharmacology: ischemia, bleeding, the ISAR research group, and a commitment to progress.
Coron Artery Dis
; 25(6): 453-5, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25072657